SC
GMED icon

Skylands Capital’s Globus Medical GMED Stock Holding History

Skylands Capital’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-13,500
Closed -$272K – 234
2013
Q4 		$272K Buy
+13,500
New +$251K 0.03% 189

Other funds holding GMED

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.51B AUM 37.25% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CCM
Century Capital Management Boston, Massachusetts $581M AUM 29.61% 1-Year Est. Return

Skylands Capital's GMED Position: Q1 2014 in Review

Skylands Capital sold out of Globus Medical (GMED) in Q1 2014, closing a stake of 13,500 shares — an estimated $272K sold.

Skylands Capital first reported a position in GMED in Q4 2013 and held it in 1 quarter. The position peaked at $272K in Q4 2013. 158 funds tracked by Wall St. Rank hold GMED as of Q1 2014.

  • Skylands Capital reported no remaining Globus Medical position as of Q1 2014 after selling out during the quarter.
  • Skylands Capital sold 13,500 Globus Medical shares in Q1 2014, an estimated $272K.
  • Skylands Capital first reported a position in Globus Medical in Q4 2013 and held it in 1 quarter.
  • Skylands Capital's Globus Medical position peaked at $272K in Q4 2013.
  • 158 funds tracked by Wall St. Rank held Globus Medical as of Q1 2014.

Based on Skylands Capital's 13F filing for Q1 2014, filed 21 Apr 2014.